Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.

Blocking proteins could pull the plug on power for colon tumours

Blocking proteins could pull the plug on power for colon tumours

Novel emerging nano-assisted anti-cancer strategies based on the STING pathway

Novel emerging nano-assisted anti-cancer strategies based on the STING pathway

Hybrid nanoparticles shine new light on targeting cancer cells

Hybrid nanoparticles shine new light on targeting cancer cells

Researchers discover iron-targeting approaches to halt proliferation of cancer cells

Researchers discover iron-targeting approaches to halt proliferation of cancer cells

How should clinicians prescribe opioids for cancer-related pain in patients who use cocaine or methamphetamines?

How should clinicians prescribe opioids for cancer-related pain in patients who use cocaine or methamphetamines?

Researchers show results of CAR-T-cell therapy without side effects in preclinical models

Researchers show results of CAR-T-cell therapy without side effects in preclinical models

New resource on helping to prevent venous thromboembolism a leading cause of cancer-related deaths

New resource on helping to prevent venous thromboembolism a leading cause of cancer-related deaths

Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

Study finds association between being breastfed as an infant and risk of colorectal cancer as an adult

Global surge in cancers among the under 50s over past three decades

Global surge in cancers among the under 50s over past three decades

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma expressing PD-L1

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2...

More from ecancer